Blog
Emily Whitehead was born on May 2nd of 2005, a perfectly healthy baby. When she reached five, her parents noticed bruising on her legs, bleeding…
Blog
Cancer is a leading cause of death worldwide. Despite the lack of a definitive cure for cancer, there are many types of cancer treatments. A…
Case Study
Learn more about how PRA worked with a sponsor to create higher enrollment rates and more extensive country selection. Discover how they did this by…
Newsletter
As we work our way through October and deeper into autumn, there have been many recent developments in healthcare and clinical research. There’s a…
Case Study
A case study describing two Phase II, multicenter studies assessing the efficacy and safety of an autologous cellular therapy treatment.
Case Study
PRA has experience partnering with small biotech firms, and we understand that they require a different approach than larger pharmaceutical…
Blog
Now that the RACE for Children Act has come into effect, the drug development industry and patients and their families are optimistic—more drugs will…
Newsletter
With fall in the air in the northern hemisphere, it’s also a week full of noteworthy news in clinical development. New research shines a light on…
Blog
This strategic relationship brings together best-in-class technologies that improve the identification, screening, and matching of cancer patients to…
Blog
PRA has partnered with The Leukemia and Lymphoma Society (LLS) on a global precision medicine clinical trial for children with relapsed acute…